IOVS Blood
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2005;46:703-708.)
© 2005 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0934
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okabe, K.
Right arrow Articles by Ogura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okabe, K.
Right arrow Articles by Ogura, Y.

Effect of Benzalkonium Chloride on Transscleral Drug Delivery

Komei Okabe,1 Hideya Kimura,2 Junko Okabe,1 Aki Kato,1 Hideo Shimizu,3 Takashi Ueda,4 Shouichi Shimada,4 and Yuichiro Ogura1

1From the Departments of Ophthalmology and Visual Science and 4Molecular Morphology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; the 2Nagata Eye Clinic, Nara, Japan; and the 3Collaborative Research Center, Nagoya City University Medical School, Nagoya, Japan.

PURPOSE. To investigate the effect and safety of benzalkonium chloride on transscleral drug delivery in the rabbit after continuous intrascleral administration.

METHODS. Betamethasone 21-phosphate (BP) aqueous solutions, with or without benzalkonium chloride (BAK), were continuously administered to albino rabbit sclera with an osmotic pump for 1 week. The BP concentrations in the aqueous humor, vitreous, and retina-choroid were measured by high-performance liquid chromatography (HPLC). To investigate the effect of BAK on scleral permeability of BP in vitro, penetration of BP aqueous solution with or without BAK across the rabbit sclera was evaluated using a two-chamber Ussing apparatus. To determine the effects of BAK on transscleral delivery of large molecules, 20- and 70-kDa fluorescein isothiocyanate (FITC)-dextran (FD-20 and -70, respectively) aqueous solutions, with or without BAK, were continuously administered to the sclera by an osmotic pump. The intensity of fluorescence in the aqueous humor, vitreous, and retina-choroid was measured by fluorescence spectrophotometry at 1 week after implantation of the pump. The retinal toxicity of BAK was evaluated electrophysiologically and histologically.

RESULTS. BAK increased concentrations of BP in the vitreous and retina-choroid compared with the control. BP was not detected in the aqueous humor. In the in vitro study, BAK did not increase the scleral permeability of BP. In the retina-choroid, BAK significantly increased concentrations of FD-20 but did not increase those of FD-70. The addition of BAK did not increase concentrations of FD-20 or -70 in the vitreous. No substantial toxic reactions were observed in the retina in electrophysiological or histologic examinations after the addition of BAK.

CONCLUSIONS. The results of this study demonstrate that BAK may improve the ocular penetration of a drug in a transscleral drug delivery system without producing toxic reactions.




This article has been cited by other articles:


Home page
 IOVSHome page
A. C. Amrite, H. F. Edelhauser, and U. B. Kompella
Modeling of Corneal and Retinal Pharmacokinetics after Periocular Drug Administration
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 320 - 332.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
Annual Review of Cosmetic Ingredient Safety Assessments: 2005/2006
International Journal of Toxicology, January 1, 2008; 27(1_suppl): 77 - 142.
[Full Text] [PDF]

Home page
 IOVSHome page
M. G. Ghosn, V. V. Tuchin, and K. V. Larin
Nondestructive Quantification of Analyte Diffusion in Cornea and Sclera Using Optical Coherence Tomography
Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2726 - 2733.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. L. Jackson, A. Hussain, A. Hodgetts, A. M. S. Morley, J. Hillenkamp, P. M. Sullivan, and J. Marshall
Human Scleral Hydraulic Conductivity: Age-Related Changes, Topographical Variation, and Potential Scleral Outflow Facility
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4942 - 4946.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Association for Research in Vision and Ophthalmology